Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience
- PMID: 36063282
- PMCID: PMC9442569
- DOI: 10.1007/s10840-022-01319-5
Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience
Erratum in
-
Correction to: Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience.J Interv Card Electrophysiol. 2023 Mar;66(2):483. doi: 10.1007/s10840-022-01458-9. J Interv Card Electrophysiol. 2023. PMID: 36542314 Free PMC article. No abstract available.
Abstract
Background: The strategy of cardiac implantable electronic device (CIED) implantations performed as day-case admissions has gained a wider acceptance overtime; however, data on safety are still limited. This study aims to investigate the safety of a same-day discharge protocol introduced in our hospital for the postprocedural management of patients undergoing CIED implantation.
Methods: Α prospective, non-interventional, non-randomised study performed in a single high-volume implanting centre for a 16-month period (March 2020 to June 2021). At total of 821 of 965 (85.1%) patients scheduled for elective CIED implantation were considered to be eligible for inclusion in the Short-stay Device Management Protocol. These patients were compared with a historical group of 932 patients, meeting the same inclusion criteria.
Results: Procedure was successful in 812 patients (98.9%), committed to same-day discharge versus 921 of 932 patients (98.8%) admitted for overnight stay (p = 0.87). Overall, 90-day complication rate was comparable in both groups (4.14% vs 4.07%, p = 0.95), as was major (1.46% vs. 1.82%, p = 0.55) and minor (2.67% vs. 2.25%, p = 0.64) complication rates. The composite early post-procedural complication rates and late post-procedural complication rates were comparable among groups (0.97 vs 1.18%, p = 0.70 and 0.73% vs 0.64%, p = 0.83, respectively). Six hundred sixty-seven patients (84%) preferred the same-day discharge strategy. Finally, a reduction of 792 bed-days was recorded, resulting in possible financial Health System benefits.
Conclusions: Same-day discharge is feasible and safe in the majority of patients referred for CIED implantation. Additionally, same-day discharge is preferred by patients and may reduce procedure-related costs due to significant bed-day reductions.
Keywords: COVID-19 pandemic; Cardiac implantable electronic device; Early discharge; Implantable cardioverter defibrillator; Pacemaker implantation; Pacemaker implantation complications.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
What could go wrong: a risk-based strategy for patient discharge after CIED procedures.J Interv Card Electrophysiol. 2023 Mar;66(2):255-256. doi: 10.1007/s10840-022-01394-8. Epub 2022 Oct 22. J Interv Card Electrophysiol. 2023. PMID: 36271975 Free PMC article. No abstract available.
References
-
- Raatikainen MJ, Arnar DO, Merkely B, et al. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. Europace. 2016;18Suppl3:iii1-iii79. - PubMed
-
- Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J.2013;34:22812329. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical